entospletinib

entospletinib
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2017-06-15 00:00:00
Sponsor Gilead Sciences (formerly Corus Pharma);199 East Blaine St;Seattle, Washington, 98102